VNRX - Conference and earnings call announcements

HENDERSON, Nev., Oct. 17, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), and its subsidiary, Volition Veterinary Diagnostics Development LLC, in line with their corporate social responsibility strategy announces participation at the HOPE Animal-Assisted Crisis Response Dogs (HOPE AACR) Annual Conference in Virginia Beach. Volition donated its Nu.Q® Vet Cancer Test to support dogs that provide emotional comfort and support to people affected by crises and disasters across the United States.   Dr. Michelle Silver, DVM, DACVIM – Oncology, commented: "Ensuring our crisis canines are healthy is our number one priority. Throughout my career in veteri

HENDERSON, Nev., Oct. 2, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announces the sponsorship of a GenomeWeb webinar entitled "Beyond the Genome: Measuring Epigenetic Modifications Across Matrices for Biomarker and Drug Discovery" on Wednesday, October 8 (details can be found below). Dr. Jasmine Kway, Chief Executive Officer, Singapore Volition, said: "This webinar will showcase our Nu.Q® Discover service and how it provides drug developers and scientists a range of state-of-the-art assays for rapid epigenetic profiling in disease model development, preclinical testing, and clinical studies." Details of the Webinar: Beyond t

HENDERSON, Nev., March 27, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announces it will host a virtual investor event on Wednesday, April 9, 2025, at 10:00 AM ET, featuring Volition's Gael Forterre, Chief Commercial Officer, Dr. Andrew Retter, Chief Medical Officer and Dr. Jake Micallef, Chief Scientific Officer. To register, click here. This webinar will provide an overview following the completion of a number of large independent studies supporting the value of our Nu.Q® platform in cancer. Mr. Forterre will provide an update on Volition's progress to commercialization through both licensing and direct and indirect sales.

HENDERSON, Nev., Feb. 5, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announced it will host a virtual investor event on Friday, February 14, 2025 at 8:00 AM ET, featuring Volition company management Dr. Andrew Retter, Chief Medical Officer and Gael Forterre, Chief Commercial Officer. To register, click here. Dr. Retter will focus on Nu.Q® NETs H3.1, a promising novel biomarker for early mortality and organ dysfunction in sepsis, and an independent predictor of the need for renal replacement therapy (RRT). Recently published results from a large-scale study indicate a potential clinical utility for risk stratification and earl

Volition to participate in the upcoming 14th Annual LifeSci Partners Corporate Access Event on January 15th, 2025 at the Beacon Grand Hotel in San Francisco. HENDERSON, Nev., Dec. 12, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced that it has retained LifeSci Advisors, LLC ("LSA") a premiere life sciences corporate and financial communications agency, to provide investor relations advisory services. Cameron Reynolds, President and Group Chief Executive Officer, noted, "We warmly welcome LSA at this critical stage in Volition's corporate development. In 2024, Volition has made significant strides across all o

HENDERSON, Nev., Oct. 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison Group, to expound new data, presented at ESICM LIVES 2024, the annual congress of the European Society of Intensive Care Medicine, earlier this week.       Given the extensive size and scope of the three independent studies on the potential use of Nu.Q® NETs in sepsis management, which included over 3000 patients and more than 14,000 patient samples, the webinar aims to provide stakeholders with a comprehensive understanding of the data and offer insights into how Volition's nucleosome quantification technology could be

HENDERSON, Nevada, May 29, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, announced today that Cameron Reynolds, President and Group Chief Executive Officer, will present and be available for one-to-one meetings at the Jefferies Global Healthcare Conference in New York City. Presentation Details:Date: Wednesday, June 5, 2024Time: 3.30 pm ET (Track 3) Cameron Reynolds, President and Group CEO of Volition, said: "We are dedicated to improving outcomes for people and animals with life-altering diseases such as sepsis and cancer through earlier detection, disease and treatment monitoring. We look forward to presenting our extensive portfo

HENDERSON, Nev., Feb. 2, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison Group, to update stakeholders on recent developments and ongoing studies for its Nu.Q® NETs test. The webinar takes place on Tuesday, February 13th at 10:30 AM U.S. Eastern Time and will include updates from Volition's Mr. Gael Forterre (Chief Commercial Officer) and Dr Andrew Retter, a leading UK-based Intensive Care Consultant and Medical Consultant at Volition. Dr. Andrew Retter said: "This upcoming webinar will provide an understanding of sepsis and highlight the challenges in diagnosing, treating and moni

HENDERSON, Nev., Oct. 2, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison Group, to expound new cancer data to be presented on October 21st at ESMO 2023, the annual congress of the European Society for Medical Oncology. The webinar takes place on Thursday, October 26th at 10:30 AM U.S. Eastern Time and will include updates from Volition's Dr. Jake Micallef (Chief Scientific Officer) and Mr. Gael Forterre (Chief Commercial Officer), and Dr Andrew Retter, a leading UK-based Haematologist and Medical Consultant at Volition. Dr. Jake Micallef, Chief Scientific Officer at Volition, said: "Our upco

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its Spotlight Emerging Growth Invitational Investor Conference on January 25, 2023. The conference, which is open to all retail and institutional investors, will consist of a series of twenty-five-minute presentations by public company management teams – followed by an analyst-moderated question-and-answer session. "The Diamond Equity Research Emerging Growth Invitational offers a unique opportunity for investors to evaluate under the radar public companies and ask relevant questions directly to management in a streamlined, convenient form

HENDERSON, Nev., Jan. 20, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison Group, which will focus on Volition's Nu.Q® Vet commercial strategy. The webinar takes place on Thursday, January 26th at 12 noon U.S. Eastern Time and will include updates from Dr. Tom Butera (Chief Executive Officer) and Dr. Heather Wilson Robles (Chief Medical Officer) of Volition Veterinary Diagnostics Development LLC,  and Gael Forterre, Volition's Chief Commercial Officer. The panel and Q&A event is being hosted by Soo Romanoff, Managing Director of Healthcare at Edison Group. It follows the release this week of '

HENDERSON, Nev., Nov. 10, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, has been invited to participate in a government-backed prospective study to evaluate the performance of blood biomarkers in the early detection of lung cancer with Hospices Civils de Lyon ("HCL"), France's second largest university hospital. The Lyonnaise Initiative for the Initiation of Lung Cancer Screening ("ILYAD") is a wide-ranging clinical study assessing the feasibility of a lung cancer screening program and the effectiveness of screening. The ILYAD study will evaluate the performance of Volition's Nu.Q® test as a blood biomarker for the early detection of

NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its Spotlight Emerging Growth Invitational Investor Conference on October 4, 2022. The conference, which is open to all retail and institutional investors, will consist of a series of twenty-five-minute presentations by public company management teams – followed by an analyst-moderated question-and-answer session. "The Diamond Equity Research Emerging Growth Invitational offers a unique opportunity for investors to evaluate under the radar public companies and ask relevant questions directly to management in a streamlined, convenient forma

NEW YORK, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its Spotlight Emerging Growth Invitational Investor Conference on October 4, 2022. The conference, which is open to all retail and institutional investors, will consist of a series of twenty-five-minute presentations by public company management teams – followed by an analyst-moderated question-and-answer session. "The Diamond Equity Research Emerging Growth Invitational offers a unique opportunity for investors to evaluate under the radar public companies and ask relevant questions directly to management in a streamlined, convenient

HENDERSON, Nev., Sept. 12, 2022 (GLOBE NEWSWIRE) -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, today announced that Scott Powell, EVP of Investor Relations at VolitionRx Limited and Chief Financial Officer of Volition America Inc., will present live at LifeSciencesInvestorForum.com on September 15th. DATE: September 15, 2022TIME: 10:00 am ETLINK:   https://bit.ly/3StcgIH Available for 1x1 meetings: Friday, September 16, 2022 from 12:00 pm – 5:00 pm ET This will be a live, interactive online event

Henderson, Nevada--(Newsfile Corp. - August 3, 2022) - VolitionRx Limited (NYSE:VNRX) today announced that company executives Cameron Reynolds, CEO, and Scott Powell, Head of Investor Relations, will be attending the Q3 Virtual Investor Summit. During the presentation, VolitionRx Limited's Chief Executive Officer, Cameron Reynolds, will highlight the Company's transformational business strategy, disruptive technology, noteworthy collaborations and partnerships, and the broader going-forward corporate vision. The presentation will be webcast and an archived recording will be made available in Investors' section of the VolitionRx Limited website. Event: Q3 Investor Summit Date: August 16 & 17t

  HENDERSON, Nev., July 13, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, in collaboration with researchers at the University of Namur and QUALIblood in Belgium has published a poster presentation entitled "Evaluation and comparison of NETosis biomarkers in sepsis and COVID-19 patients" at the International Society on Thrombosis and Haemostasis (ISTH) Congress earlier this week.   Commenting on the poster, joint lead author Professor Jonathan Douxfils, University of Namur and QUALIblood's Chief Executive and Scientific

NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its quarterly Emerging Growth Invitational investor conference on June 23, 2022. The conference, which is open to all retail and institutional investors, will consist of a series of twenty-five-minute presentations by public company management teams – followed by an analyst-moderated question-and-answer session. "The Diamond Equity Research Emerging Growth Invitational offers a unique opportunity for investors to evaluate under the radar public companies and ask relevant questions directly to management in a streamlined, convenient format

NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will host its quarterly Emerging Growth Invitational investor conference on February 24, 2022. The conference, which is open to all retail and institutional investors, will consist of a series of twenty five minute presentations by public company management teams – followed by an analyst-moderated question-and-answer session. "The Diamond Equity Research Emerging Growth Invitational offers a unique opportunity for investors to evaluate under the radar public companies and ask relevant questions directly to management in a streamlined, convenient for

NEW YORK, Dec. 20, 2021 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the December 16th Life Sciences Virtual Investor Conference are now available for on-demand viewing. This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company's "virtual trade booth". REGISTER OR LOGIN N

Company executives will share corporate vision and answer audience questions at VirtualInvestorConferences.com NEW YORK, Dec. 14, 2021 /CNW/ - Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry. Individual investors, institutional investors, advisors, and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, December 16th with the first live webcast at 9:30 AM ET. R

NEW YORK, Dec. 9, 2021 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry. Individual investors, institutional investors, advisors, and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, December 16th with the first live webcast at 9:3

Presentation Times Released for 75+ Presenting CompaniesWednesday and Thursday, December 8-9, 2021NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day December Micro Cap Virtual Conference taking place Wednesday and Thursday, December 8 - 9, 2021. The links can also be found at www.sidoticonference.com/events.Group Presentation Schedule(click on co. names below to register & watch)Wednesday, December 8th, 2021 (Day 1)*All Times EST8:30-9:00u-blox Holding AG (UBXN)****EQONEX (EQOS)Slinger (SLBG)9:15-9:45Rekor Systems, Inc. (REKR)Culp, Inc. (CULP)Transcat, Inc. (TRNS)Mistras Group (MG)10:00-10:30Amesite Inc. (A

30 Minute presenting time slots from 9am to 1pm EST November 16, 2021Presentation times and links distributed for all presenting companiesInvestors will be provided time after presentation to ask questionsWelcome all institutional and retail investors NEW YORK, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Investors can register at https://www.diamondequityresearch.com/conferences/ or using the company specific links below. Virtual Agenda – Tuesday, November 16, 2021 9:00am-9:30amVolitionRX Limited (NYSE:VNRX)9:40am-10:10amEqonex Limited (NASDAQ:EQOS)10:20am-10:50amColor Star Technology Co., Ltd. (NASDAQ:CSCW)11:00am-11:30amApplied UV, Inc. (NASDAQ:AUVI)11:40am-12:10pmAmesite Inc. (NASDAQ:AMST)12:20

New York, New York--(Newsfile Corp. - November 8, 2021) - The Investor Summit Group, widely recognized for its reputation as the host of North America's largest independent investor conferences, will be hosting the upcoming Q4 Virtual Summit on November 16-17. The event will bring together some of the continent's most exciting and influential small and micro-cap companies, providing presenting companies with the unique opportunity to meet and interact with leading investors.This year's Q4 Virtual Summit will feature a selection of more than 90 carefully curated companies drawn from a wide variety of sectors, including healthcare, financial, technology, crypto, energy, industrials, financials

NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The Investor Summit Group, widely recognized for its reputation as the host of North America's largest independent investor conferences, will be hosting the upcoming Q4 Virtual Summit on November 16-17. The event will bring together some of the continent's most exciting and influential small and micro-cap companies, providing presenting companies with the unique opportunity to meet and interact with leading investors. This year's Q4 Virtual Summit will feature a selection of more than 90 carefully curated companies drawn from a wide variety of sectors, including healthcare, financial, technology, crypto, energy, industrials, financials, and

A Conference Open to All Classes of Investors70+ Companies Presenting and Meeting Interested Investors 1x1Wednesday and Thursday, December 8-9, 2021NEW YORK, NY / ACCESSWIRE / November 5, 2021 / Sidoti & Company, LLC has updated its preliminary list of presenting companies for its two-day Microcap Virtual Conference, taking place Wednesday and Thursday, December 8 - 9, 2021. Currently over 70 microcap companies are expected to present. Sidoti events are open to every class of investor, including client and non-client institutions, family offices, high net worth individuals and retail investors of all sizes. Register at www.sidoti.com/events to learn more about our conference and gain access

Presentation Times Released for 50 Presenting CompaniesWednesday and Thursday, August 18-19, 2021NEW YORK, NY / ACCESSWIRE / August 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day summer Microcap Virtual Conference taking place Wednesday and Thursday, August 18 - 19, 2021. The links can also be found at www.sidoticonference.com/events.Group Presentation ScheduleClick Here to Login / Register for the ConferenceWednesday, August 18th, 2021 (Day 1)*All Times EDT8:30-9:00BlueCity (BLCT)Mistras Group (MG)Venus Concept Inc. (VERO)9:15-9:45BK Technologies (BKTI)Solar Alliance Energy (SOLR)Neovasc Inc. (NVCN)10:00-10:30Minim, Inc. (MINM)Alico, Inc

30 Minute presenting time slots from 9am to 12pm EST August 17th, 2021Presentation times and links distributed for all presenting companiesInvestors will be provided time after presentation to ask questions to management teamsWe welcome all institutional and retail investors NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Investors can register at https://www.diamondequityresearch.com/conferences/ or using the company specific links below. Agenda – August 17th, 2021 9:00-9:30VolitionRX Limited (NYSE:VNRX)9:40-10:10Blue Star Foods Corp. (OTC:BSFC)10:20-10:50Color Star Technology Co., Ltd. (NASDAQ:CSCW)11:00-11:30Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX)11:40-12:10Boxlight Corporation (NASD

NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the June 24th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company's "virtual trade booth". REGISTER OR LOGIN AT:  https://bit.ly/3j2S9Si June 24th Presenting Companies: Presenting CompanyTicker(s)Cybin Inc.(OTCQB:CLXPF, NEO: CYBN)))Else Nutrition Holdings Inc(

NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry. Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 8:45 AM ET on Thursday, June 24th with the first live webcast at 9:00 AM ET. REGISTER NOW AT: https://bit.ly/2P9cmZK It is recommended that investors pre-register and run the online system check to expedite par

AUSTIN, Texas, June 21, 2021 (GLOBE NEWSWIRE) -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, today announced that Scott Powell, EVP of Investor Relations and Chief Financial Officer of Volition America Inc., will present live at LifeSciencesInvestorForum.com on June 24th. DATE: Thursday, June 24th      TIME: 1:30 PM ETLINK: https://bit.ly/3c7Ertp This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live o

May 19 - 20, 2021Presentation times and weblinks released for over 60 presenting companiesNEW YORK, NY / ACCESSWIRE / May 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day spring Microcap Virtual Conference taking place Wednesday and Thursday, May 19 - 20, 2021. The links can also be found at www.sidoticonference.com/events.Group Presentation Schedule(click on the company name to register & watch)Wednesday, May 19th, 2021 (Day 1)*All Times EDT8:30-9:00Lincoln Education Services (LINC)Bassett Furniture (BSET)Real Luck Group (LUCK)****9:15-9:45Medexus Pharmaceuticals (MDP)Hill International (HIL)Pangaea Logistics Solutions (PANL)Zoom Telephoni

AUSTIN, Texas, March 22, 2021 (GLOBE NEWSWIRE) -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, today announced that Scott Powell, EVP of Investor Relations and Chief Financial Officer of Volition America Inc., will present live at LifeSciencesInvestorForum.com on March 25th. DATE: Thursday, March 25thTIME: 11:00 AM ETLINK: https://bit.ly/3qVRFyI This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the

NEW YORK , March 19, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry. Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:45 AM ET on Thursday, March 25th with the first live webcast at 10:00 AM ET. REGISTER NOW AT: https://bit.ly/2P9cmZK It is recommended that investors pre-register and run the online system check to expedite

AUSTIN, Texas, March 8, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its Chief Executive Officer, Cameron Reynolds, and its Executive Vice President, Investor Relations, Scott Powell, are scheduled to present at six conferences in March 2021. During the conferences, Mr. Reynolds and Dr. Powell will outline Volition's business, clinical, regulatory and operational milestones. Details of the conference presentations (all virtual) are as follows: H.C. Wainwright Global Life Sciences Conference - March 9-10, 2021Presentation: Tuesday March 9 at 7:00 am ETRegister: https://hcwevents.com/globalconference/ Maxim 2021 Emerging Growth Virtual Confere

NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the February 4th Small and Microcap Showcase are now available for on-demand viewing. REGISTER OR LOGIN NOW TO VIEW THE PRESENTATIONS: https://bit.ly/3pPZeWX The company presentations will be available 24/7 for 90 days. Investors, advisors and analysts may download shareholder materials from the "virtual trade booth" for the next three weeks. Participating Companies: Full Company Legal Name - Presentation Name Ticker Keynote Presentation: Investing 101: Evaluating a Public Company's Corporate Communications Efforts

AUSTIN, Texas, Feb. 1, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, today announced that Scott Powell, EVP of Investor Relations and Chief Financial Officer of Volition America Inc., will present live at VirtualInvestorConferences.com on February 4th.    DATE: February 4th, 2021TIME: 12:00 PM ESTLINK: https://bit.ly/3brvZ8w This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event

NEW YORK, Jan. 28, 2021 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Small and Microcap Showcase.  Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 8:45 AM ET on Thursday, February 4th  with the first live webcast at 9:00 AM ET. REGISTER NOW AT https://bit.ly/2KEhljn It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend the live presentations or ask questions. "We are pleased to highlight a diverse array of companies par

AUSTIN, Texas, Dec. 1, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has announced the launch of its first product, the Nu.Q™ Vet Cancer Screening Test. An interview with Cameron Reynolds and Professor Heather Wilson-Robles The test, which as of yesterday is available to order by veterinarians in the U.S. from the GI Lab at Texas A&M University, is positioned for use in the annual wellness check of older dogs or for cases where there is a suspicion of cancer. It